Literature DB >> 9493124

Influence of oxidized low-density lipoprotein on vascular angiotensin II receptor expression.

G Nickenig1, A Sachinidis, S Seewald, M Böhm, H Vetter.   

Abstract

OBJECTIVES: To investigate the effect of oxidized low-density lipoprotein (LDL) on angiotensin type 1 (AT1) receptor expression and on angiotensin-induced mitogenesis in vascular smooth muscle cells.
DESIGN: Since both LDL and the AT1 receptor are thought to be involved in the pathogenesis of chronic vascular disease, we studied possible interactions between these two biological systems in cultured rat vascular smooth muscle cells. Recent studies have demonstrated that native LDL profoundly increases the AT1 receptor gene expression in vascular smooth muscle cells. The present study was designed to show whether an oxidative modification of LDL, which has been implicated as a major participant in atherogenesis, has similar effects on vascular smooth muscle cells.
MATERIALS AND METHODS: Vascular smooth muscle cells isolated from rat thoracic aorta were cultured with oxidized LDL and assessed for their ability to synthesize DNA, and messenger (m)RNA expression, using Northern blot technology.
RESULTS: Oxidized LDL had no significant effect on AT1 receptor mRNA steady-state levels when incubated for 0-24 h. Moreover, oxidized LDL itself had no stimulatory effect on DNA synthesis in vascular smooth muscle cells, nor was the angiotensin II-induced increase in DNA synthesis influenced by oxidized LDL.
CONCLUSIONS: These data show that in contrast to native LDL, oxidized LDL has no effect on AT1 receptor mRNA expression and no effect on angiotensin II-induced mitogenesis in vascular smooth muscle cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9493124     DOI: 10.1097/00004872-199715066-00006

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  8 in total

Review 1.  Hypertension and lipids: lipid factors in the hypertension syndrome.

Authors:  Gary E Sander; Thomas D Giles
Journal:  Curr Hypertens Rep       Date:  2002-12       Impact factor: 5.369

2.  Angiotensin and systems thinking: wrapping your mind around the big picture.

Authors:  Gary Robert Smith
Journal:  Ochsner J       Date:  2013

3.  The M235T polymorphism of the AGT gene modifies the risk of coronary artery disease associated with the presence of hypercholesterolemia.

Authors:  Pawel Niemiec; Iwona Zak; Krystian Wita
Journal:  Eur J Epidemiol       Date:  2008       Impact factor: 8.082

4.  GW3965, a synthetic liver X receptor (LXR) agonist, reduces angiotensin II-mediated pressor responses in Sprague-Dawley rats.

Authors:  C E Leik; N L Carson; J K Hennan; M D Basso; Q-Y Liu; D L Crandall; P Nambi
Journal:  Br J Pharmacol       Date:  2007-04-10       Impact factor: 8.739

Review 5.  Adipose Tissue and Modulation of Hypertension.

Authors:  Eashita Das; Joon Ho Moon; Ju Hee Lee; Nikita Thakkar; Zdenka Pausova; Hoon-Ki Sung
Journal:  Curr Hypertens Rep       Date:  2018-09-18       Impact factor: 5.369

6.  Why do antioxidants fail to provide clinical benefit?

Authors:  Ascan Warnholtz; Thomas Münzel
Journal:  Curr Control Trials Cardiovasc Med       Date:  2000

7.  The relationship between plasma renin activity and serum lipid profiles in patients with primary arterial hypertension.

Authors:  Tomasz Pizoń; Marek Rajzer; Wiktoria Wojciechowska; Małgorzata Wach-Pizoń; Tomasz Drożdż; Katarzyna Wróbel; Krystian Gruszka; Marta Rojek; Tomasz Kameczura; Artur Jurczyszyn; Janusz Kąkol; Danuta Czarnecka
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2018 Oct-Dec       Impact factor: 1.636

Review 8.  Therapeutic interventions and oxidative stress in diabetes.

Authors:  Shilpa Rahangdale; Susie Yim Yeh; Atul Malhotra; Aristidis Veves
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.